Michael Kalb, Chief Financial Officer
Professional Overview
Michael Kalb is an accomplished finance executive with over 20 years of experience in the pharmaceutical industry. As the Chief Financial Officer at Impel Pharmaceuticals, he is responsible for overseeing all financial operations, strategic planning, and driving the company's financial growth and profitability.
Experience Summary
Current Role
As the Chief Financial Officer at Impel Pharmaceuticals since May 2023, Michael is responsible for leading the company's financial strategy, managing financial reporting and compliance, and collaborating with the executive team to support the organization's long-term objectives. He plays a critical role in securing funding, optimizing financial performance, and ensuring the company's financial stability and sustainability.
Career Progression
Prior to his current role, Michael held senior finance positions at several prominent pharmaceutical companies. He served as the EVP and Chief Financial Officer at CinCor Pharma, Inc. from 2022 to 2023, where he played a pivotal role in the company's successful initial public offering. Before that, he was the SVP and Chief Financial Officer at Amarin Corporation from 2016 to 2022, where he was instrumental in driving the company's financial growth and strategic initiatives. Michael also held the role of Chief Financial Officer and Chief Accounting Officer, Group V.P. at Taro Pharmaceuticals from 2009 to 2016.
Earlier in his career, Michael gained valuable experience as a Director at Huron Consulting Group and as a Senior Manager at Grant Thornton and Ernst & Young, where he honed his expertise in financial analysis, strategic planning, and transaction advisory services.
Academic Background
Michael holds a Bachelor's degree in Accounting from the University at Albany.
Areas of Expertise
- Financial management and reporting
- Strategic planning and budgeting
- Fundraising and capital markets
- Financial modeling and analysis
- Mergers, acquisitions, and integration
- Regulatory compliance and risk management
- Leadership and team building
Professional Impact
Throughout his career, Michael has demonstrated a track record of driving financial excellence and supporting the growth and success of pharmaceutical companies. He has a deep understanding of the industry's unique challenges and opportunities, and his strategic insights and financial acumen have been instrumental in helping organizations navigate complex market dynamics and achieve their objectives.
Conclusion
With his extensive experience, strong financial expertise, and a proven ability to collaborate with cross-functional teams, Michael Kalb is well-positioned to lead Impel Pharmaceuticals' financial strategy and contribute to the company's long-term success. His commitment to financial rigor, combined with his strategic vision, makes him a valuable asset to the organization.
